Steven De Jonghe

4.7k citations

131 papers · 2.4k indexed · 1 hit paper · h-index 25

Infectious Diseases top 2%
Molecular Biology top 10%
Organic Chemistry top 2%
Epidemiology top 10%
Computational Theory and Mathematics top 2%

Co-authors: Piet Herdewijn Johan Neyts Dirk Jochmans Laura Vangeel Piet Maes Jef Rozenski Pieter Leyssen Winston Chiu
Topics: Biochemical and Molecular Research (26 papers)HIV/AIDS drug development and treatment (24 papers)Synthesis and biological activity (16 papers)
Cited by: Infectious Diseases Organic Chemistry Physiology
Journals: Journal of Clinical Investigation Nature Communications The Journal of Immunology
Partner nations: Belgium United States China

In The Last Decade

Steven De Jonghe

124 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

2022 290 citations Laura Vangeel, Winston Chiu et al. Antiviral Research profile →

Peers

Countries citing papers authored by Steven De Jonghe

Since Specialization

Citations

This map shows the geographic impact of Steven De Jonghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven De Jonghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven De Jonghe more than expected).

Fields of papers citing papers by Steven De Jonghe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven De Jonghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven De Jonghe. The network helps show where Steven De Jonghe may publish in the future.

Co-authorship network of co-authors of Steven De Jonghe

This figure shows the co-authorship network connecting the top 25 collaborators of Steven De Jonghe. A scholar is included among the top collaborators of Steven De Jonghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven De Jonghe. Steven De Jonghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New 1,2,3-triazole-α-aminophosphonate acyclic nucleosides scaffold: Design, synthesis, docking studies and biological evaluation as potential S. aureus agents 2025 ·Journal of Molecular Structure ·(unknown),(unknown),(unknown),Az‐eddine El Mansouri,Mohamed Maatallah,Ahmad Mehdi,Johan Neyts,Dirk Jochmans,Steven De Jonghe,(unknown),Yogesh S. Sanghvi,Mustapha Ait Ali,Hassan B. Lazrek	0
2	Structure–Activity Relationship Study of 3-Alkynyl-6-aryl-isothiazolo[4,3-b]pyridines as Dual Inhibitors of the Lipid Kinases PIKfyve and PIP4K2C 2025 ·Pharmaceuticals ·(unknown),Ling‐Jie Gao,(unknown),(unknown),Sirle Saul,Tran Do Hoang Nhu,Jef Rozenski,Leentje Persoons,Dominique Schols,Wim Dehaen,Shirit Einav,Steven De Jonghe	0
3	Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual Screening 2025 ·International Journal of Molecular Sciences ·(unknown),Na Liu,Fabao Zhao,Dongwei Kang,Steven De Jonghe,Johan Neyts,Ni Gao,Xinyong Liu	0
4	Synthesis and functional screening of novel inhibitors targeting the HDAC6 zinc finger ubiquitin-binding domain 2024 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Jeroen de Ridder,Leentje Persoons,Steven De Jonghe,Dominique Schols,Mandeep Mann,Rachel Harding,Jorick Franceus,Tom Desmet,Kristof Van Hecke,Dorien Clarisse,Karolien De Bosscher,Matthias D’hooghe	1
5	Synthesis of a 3,7-Disubstituted Isothiazolo[4,3-b]pyridine as a Potential Inhibitor of Cyclin G-Associated Kinase 2024 ·Molecules ·(unknown),(unknown),Matheus Froeyen,Dominique Schols,Luc Van Meervelt,Steven De Jonghe,Wim Dehaen	2
6	Synthesis of 3-heteroaryl-pyrrolo[2,3-b]pyridines as potent inhibitors of AP-2-associated protein kinase 1 (AAK1) with antiviral activity 2024 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Tran Do Hoang Nhu,Aditi Agrawal,Dominique Schols,Arnout Voet,Shirit Einav,Wim Dehaen,Steven De Jonghe	2
7	Protecting Group Control of Hydroxyketone-Hemiketal Tautomeric Equilibrium Enables the Stereoselective Synthesis of a 1′-Azido C-Nucleoside 2024 ·The Journal of Organic Chemistry ·(unknown),(unknown),Tej Narayan Poudel,Steven De Jonghe,Dirk Jochmans,Johan Neyts,Courtney C. Aldrich	1
8	A new alkaloid from Pancratium maritimum - Structure elucidation using computer-assisted structure elucidation (CASE) and evaluation of cytotoxicity and anti-SARS-CoV-2 activity 2023 ·Phytochemistry Letters ·(unknown),Steven De Jonghe,(unknown),Johan Neyts,Christophe Pannecouque,(unknown),Wouter Herrebout,Luc Pieters,Emmy Tuenter	4
9	Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells 2023 ·Chemical Science ·Roeland Vanhoutte,Marta Barniol‐Xicota,Winston Chiu,Laura Vangeel,Dirk Jochmans,Steven De Jonghe,(unknown),Haim Barr,Nir London,Johan Neyts,Steven H. L. Verhelst	7
10	Photo-induced scandium-catalyzed biomimetic skeleton conversion of lathyrane to naturally rare eupholathone Euphorbia diterpenes 2023 ·Chemical Communications ·(unknown),Wen Li Peng,Neng Wang,Xiaohuan Li,Jiahong Li,Steven De Jonghe,Dominique Schols,(unknown),Feng Gao	3
11	Synthesis and structure–activity relationship study of phenoxybenzylpiperazine analogues as CCR8 agonists 2023 ·Bioorganic Chemistry ·Qifei Li,Sandra Claes,(unknown),(unknown),Tom Van Loy,Dominique Schols,Wim Dehaen,Steven De Jonghe	0
12	Anti-SARS-CoV-2 Activity and Cytotoxicity of Amaryllidaceae Alkaloids from Hymenocallis littoralis 2023 ·Molecules ·(unknown),Steven De Jonghe,(unknown),(unknown),A.M. Baldé,Wouter Herrebout,Johan Neyts,Christophe Pannecouque,Luc Pieters,Emmy Tuenter	13
13	Synthesis and cancer cell cytotoxicity of 2-aryl-4-(4-aryl-2-oxobut-3-en-1-ylidene)-substituted benzothiazepanes 2023 ·Phytochemistry Letters ·(unknown),(unknown),Steven De Jonghe,Leentje Persoons,Dominique Schols,(unknown),Charlotte Grootaert,John Van Camp,Matthias D’hooghe	2
14	Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors 2022 ·Molecules ·Shenghua Gao,(unknown),Hongtao Xu,(unknown),(unknown),Steven De Jonghe,Fabao Zhao,Lanlan Jing,Dirk Jochmans,Laura Vangeel,(unknown),Dongwei Kang,Johan Neyts,Piet Herdewijn,Dominique Schols,Peng Zhan,Xinyong Liu	6
15	Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures 2022 ·Journal of Medical Virology ·Winston Chiu,(unknown),Christel Van den Eynde,Christophe Buyck,Sandra De Meyer,Dirk Jochmans,Denisa Bojková,Sandra Ciesek,Jindřich Činátl,Steven De Jonghe,Pieter Leyssen,Johan Neyts,Marnix Van Loock,Ellen Van Damme	12
16	Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery 2022 ·Antiviral Research ·Winston Chiu,(unknown),(unknown),Laura Vangeel,(unknown),Dirk Jochmans,Steven De Jonghe,Hendrik Jan Thibaut,Volker Thiel,Johan Neyts,Manon Laporte,Pieter Leyssen	10
17	Sliding of HIV-1 reverse transcriptase over DNA creates a transient P pocket – targeting P-pocket by fragment screening 2021 ·Nature Communications ·Abhimanyu K. Singh,Sergio E. Martinez,(unknown),Hoai Viet Nguyen,Dominique Schols,Piet Herdewijn,Steven De Jonghe,Kalyan Das	7
18	Exploring the dNTP -binding site of HIV-1 reverse transcriptase for inhibitor design 2021 ·European Journal of Medicinal Chemistry ·(unknown),Sergio E. Martinez,Abhimanyu K. Singh,Hoai Viet Nguyen,Jef Rozenski,Dominique Schols,Piet Herdewijn,Kalyan Das,Steven De Jonghe	3
19	1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors 2021 ·European Journal of Medicinal Chemistry ·(unknown),Tommaso Felicetti,Chiara Bertagnin,(unknown),(unknown),Maria Letizia Barreca,Violetta Cecchetti,Dirk Jochmans,Steven De Jonghe,Johan Neyts,Arianna Loregian,Oriana Tabarrini,Serena Massari	25
20	Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase 2021 ·Antiviral Research ·(unknown),(unknown),(unknown),(unknown),Laura Vangeel,Steven De Jonghe,Dirk Jochmans,Johan Neyts,Joanna Kowalska,Jacek Jemielity	27

About Steven De Jonghe

Steven De Jonghe is a scholar working on Infectious Diseases, Organic Chemistry and Physiology, having authored 131 papers that have together received 2.4k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (26 papers), HIV/AIDS drug development and treatment (24 papers) and Synthesis and biological activity (16 papers). The work is most often cited by research in Infectious Diseases (932 citations), Organic Chemistry (739 citations) and Physiology (96 citations). Steven De Jonghe has collaborated with scholars based in Belgium, United States and China. Frequent co-authors include Piet Herdewijn, Johan Neyts, Dirk Jochmans, Laura Vangeel, Piet Maes, Jef Rozenski, Pieter Leyssen, Winston Chiu, Elisabetta Groaz and Ling‐Jie Gao. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact